RBR-2 antibodies are designed to detect the protein in various experimental contexts, including Western blot (WB), immunofluorescence (IF), immunohistochemistry (IHC), and flow cytometry. These antibodies vary in specificity, host species, and epitope recognition:
| Antibody Source | Type | Host | Applications | Epitope/Specificity | Catalog Number |
|---|---|---|---|---|---|
| Affinity Biosciences | Polyclonal | Rabbit | WB | Phospho-Ser952 | AF8036 |
| Sigma-Aldrich | Polyclonal | Rabbit | WB, IF, IHC | Full-length RBL2 | HPA019703 |
| Abcam | Monoclonal | Mouse | Flow, WB | C-terminal fragment (aa 900–C-terminus) | ab201943 |
Phospho-Ser952 Specificity: The AF8036 antibody (Affinity Biosciences) recognizes phosphorylated Ser952, enabling studies of RBR-2 post-translational modifications .
Broad Reactivity: HPA019703 (Sigma-Aldrich) detects RBL2 in human, mouse, and rat samples, with applications across multiple platforms .
Flow Cytometry Utility: The ab201943 monoclonal antibody (Abcam) is optimized for detecting Rb2 p130 in human cell lines (e.g., HeLa, HEK293) .
RBR-2 interacts with chromatin-modifying enzymes (e.g., KMT5B/C) to maintain heterochromatin and regulate histone methylation (e.g., H4K20me3) . Studies using RBR-2 antibodies have revealed its role in:
Transcriptional Repression: Recruitment of RBR-2 to promoters suppresses E2F5-driven gene expression .
Tumor Suppression: Loss of RBR-2 correlates with oncogenesis, particularly in cancers with disrupted chromatin regulation .
The AF8036 antibody enables detection of RBR-2 phosphorylation at Ser952, a site implicated in modulating its activity. This modification may influence its interaction with cyclins or chromatin modifiers .
RBR-2 antibodies are used in:
WB Analysis: Confirming RBL2 expression levels in cell lysates (e.g., HEK293, HeLa) .
IF/IHC: Visualizing subcellular localization in fixed tissues or cells .
Flow Cytometry: Quantifying Rb2 p130 levels in human samples .
As highlighted in recent antibody characterization studies, rigorous validation is critical to ensure specificity and reliability :
KO Cell Line Validation: Recommended for confirming target recognition (e.g., using RBL2 knockout cells) .
Cross-Reactivity: Polyclonal antibodies may bind non-specific epitopes; monoclonal antibodies (e.g., ab201943) offer higher specificity .
| Antibody | WB Dilution | IF/IHC Dilution | Flow Cytometry Dilution | Predicted Band Size |
|---|---|---|---|---|
| AF8036 | 0.04–0.4 µg/mL | N/A | N/A | 128 kDa |
| HPA019703 | 0.04–0.4 µg/mL | 0.25–2 µg/mL | 1:200–1:500 | 130 kDa |
| ab201943 | 1:500 | N/A | 1:200 | 128 kDa |
| Feature | AF8036 | HPA019703 | ab201943 |
|---|---|---|---|
| Epitope | Phospho-Ser952 | Full-length | C-terminal fragment |
| Host | Rabbit | Rabbit | Mouse |
| Reactivity | Human, Mouse, Rat | Human, Mouse, Rat | Human |
| Optimal Use Case | Phosphorylation studies | Broad detection | Flow cytometry |
RBR-2 (Retinoblastoma Related-2) belongs to the Retinoblastoma protein family, which plays crucial roles in regulating cell cycle progression and maintaining genome integrity in eukaryotic cells. The Retinoblastoma protein family, including RBR in plants like Arabidopsis, is involved in DNA damage response pathways and interacts with several proteins to protect genomic integrity during cellular stress . When studying these pathways, specific antibodies against RBR-2 provide valuable tools for detecting protein localization, interactions, and modifications under various experimental conditions.
RBR-2 antibodies are specifically designed to recognize and bind to RBR-2 protein epitopes, distinguishing them from antibodies targeting other Retinoblastoma family members. These antibodies typically feature high specificity for their target protein, enabling researchers to study RBR-2 independently of other related proteins. Similar to other research antibodies like anti-RBP2, RBR-2 antibodies can be produced in various host animals (often rabbits) and validated for specific applications such as Western blotting, immunohistochemistry, and immunoprecipitation .
RBR-2 antibodies are particularly valuable in studying chromosome dynamics and DNA damage responses. Based on research with related proteins, these antibodies can be used to visualize protein localization at DNA damage sites through immunofluorescence microscopy. For instance, RBR in Arabidopsis accumulates at distinct heterochromatic foci labeled by γH2AX in response to DNA damage, and this localization is ATM/ATR-dependent . When designing experiments to study similar phenomena with RBR-2, researchers should consider using DNA-damaging agents like mitomycin (MMC) or zeocin to induce damage, followed by immunofluorescence using RBR-2 antibodies to track protein recruitment to damage sites.
For optimal Western blot results with RBR-2 antibodies, consider the following methodological approach based on practices with similar research antibodies:
Sample preparation: Use appropriate lysis buffers containing protease inhibitors to prevent protein degradation.
Protein loading: Load 10-20 μg of total protein per lane.
Antibody dilution: Start with a 1:1000 to 1:2000 dilution of primary antibody, similar to the 2 μg/mL concentration used for RBP2 antibodies .
Incubation conditions: Incubate with primary antibody overnight at 4°C for optimal binding.
Detection methods: HRP-conjugated secondary antibodies with enhanced chemiluminescence typically provide good results.
Controls: Always include positive controls (tissues known to express RBR-2) and negative controls (tissues with minimal expression) to validate specificity.
Effective immunoprecipitation with RBR-2 antibodies typically involves:
Cell/tissue lysate preparation in non-denaturing conditions to preserve protein-protein interactions.
Pre-clearing lysates with protein A/G beads to reduce non-specific binding.
Incubating cleared lysates with RBR-2 antibody (typically 2-5 μg per sample) overnight at 4°C.
Capturing antibody-protein complexes with protein A/G beads.
Washing extensively to remove non-specific interactions.
Eluting complexes for downstream analysis (Western blot, mass spectrometry).
Similar approaches have been successfully used to study protein interactions of RBR in Arabidopsis, revealing functional interactions with proteins like AtBRCA1 and E2FA .
For advanced studies of DNA damage response pathways, RBR-2 antibodies can be employed in several sophisticated experimental setups:
Chromatin Immunoprecipitation (ChIP): To identify genomic regions where RBR-2 binds, particularly after DNA damage induction. Based on findings with related proteins, RBR-2 might associate with specific chromatin regions during the DNA damage response .
Co-immunoprecipitation coupled with mass spectrometry: To identify novel RBR-2 interaction partners in response to different genotoxic stresses. Similar approaches revealed that RBR in Arabidopsis can interact with AtBRCA1 .
Proximity-based labeling techniques: BioID or APEX2 fusions with RBR-2 can identify transient or weak interactors in living cells during DNA damage responses.
Live-cell imaging with fluorescently tagged antibody fragments: To monitor real-time recruitment dynamics of RBR-2 to DNA damage sites.
When studying RBR-2 foci formation during DNA damage response, several important experimental considerations should be addressed:
Damage induction specificity: Different DNA-damaging agents induce different types of damage. For example, in Arabidopsis studies, MMC induced RBR recruitment to distinct heterochromatic foci, while other agents like hydroxyurea showed different patterns .
Kinetics of foci formation: Time-course experiments are essential, as RBR foci in Arabidopsis were observed in approximately 17% of examined nuclei after 16 hours of MMC treatment .
Co-localization analysis: Three-dimensional reconstruction and intensity correlation analysis are necessary to accurately assess partial co-localization with other proteins such as γH2AX .
Quantification approach: Standardized methods for counting and measuring foci intensity should be established, similar to the approaches used in the table below from Arabidopsis RBR studies:
| Foci Measurement | Root 1 | Root 2 | Root 3 | Mean | SD | Mean (%) | SD |
|---|---|---|---|---|---|---|---|
| γH2AX (total) | 156 | 144 | 152 | 151 | 6.1 | 100% | - |
| γH2AX+ RBR | 37 | 56 | 45 | 46 | 9.5 | 27% | 3% |
| γH2AX+BRCA1 | 32 | 42 | 38 | 37 | 5.0 | 25% | 4% |
| γH2AX+BRCA1+RBR | 12 | 14 | 15 | 14 | 1.5 | 9% | 1% |
This quantification approach provides robust statistical analysis of co-localization events .
Validating RBR-2 antibody specificity is critical for experimental reliability. A comprehensive validation approach includes:
Western blot analysis with positive and negative control samples to confirm the detection of a single band at the expected molecular weight.
Peptide competition assays where pre-incubation of the antibody with the immunizing peptide should abolish specific signal.
Testing in knockout/knockdown systems where the signal should be absent or significantly reduced.
Cross-reactivity testing against closely related proteins to ensure specificity within the Retinoblastoma protein family.
Immunoprecipitation followed by mass spectrometry to confirm the identity of the precipitated protein.
Comparing results from multiple antibodies targeting different epitopes of RBR-2 to confirm consistent findings.
Common immunofluorescence pitfalls and their solutions include:
High background signal:
Increase blocking stringency (5% BSA or normal serum from secondary antibody species)
Optimize antibody dilution (typically start with 1:100-1:500)
Include additional washing steps with 0.1% Triton X-100
Weak or absent signal:
Optimize antigen retrieval methods (heat-induced or enzymatic)
Increase antibody concentration or incubation time
Ensure sample fixation preserves the epitope (test multiple fixation methods)
Non-specific nuclear staining:
Use more stringent washing conditions
Pre-adsorb antibody with nuclear extracts from negative control samples
Include appropriate blocking reagents specific for nuclear components
Variability between experiments:
Standardize all protocol steps, including fixation time and temperature
Prepare master mixes of antibody dilutions
Process all experimental conditions in parallel
False co-localization:
Use appropriate controls for each fluorescent channel
Perform sequential scanning instead of simultaneous acquisition
Validate findings with super-resolution microscopy techniques
When interpreting changes in RBR-2 localization after DNA damage:
Quantify the percentage of nuclei showing RBR-2 foci formation. In studies with Arabidopsis RBR, approximately 17% of nuclei showed RBR foci after MMC treatment .
Assess the number, size, and intensity of foci per nucleus. RBR typically forms 1-5 large foci per nucleus upon DNA damage in Arabidopsis .
Determine the relationship between RBR-2 foci and chromatin markers. In Arabidopsis, approximately 80% of RBR foci localized near heterochromatin regions .
Analyze co-localization with DNA damage markers like γH2AX. Partial co-localization with a broad correlation range may indicate dynamic and transient interactions .
Compare different damage-inducing agents. Different genotoxic stresses may induce distinct RBR-2 localization patterns, as seen with MMC versus hydroxyurea in Arabidopsis studies .
Consider the kinetics of localization changes, as recruitment to damage sites may be time-dependent.
To distinguish specific from non-specific binding in RBR-2 antibody experiments:
Perform titration experiments with increasing concentrations of antibody to identify the optimal signal-to-noise ratio.
Include isotype control antibodies at the same concentration to identify non-specific binding patterns.
Use competitive binding assays with excess unlabeled antibody or immunizing peptide to demonstrate binding specificity.
Compare staining patterns across multiple tissue types with known expression levels of RBR-2.
For quantitative assays, establish clear signal thresholds based on negative controls, similar to methods used in ELISA-based antibody detection systems where specific optical density cutoffs define positive results .
When using imaging techniques, perform quantitative intensity correlation analyses between RBR-2 and known interactors or cellular compartment markers.
Adapting RBR-2 antibodies for single-cell technologies offers exciting research possibilities:
Single-cell antibody-based proteomics:
Conjugate RBR-2 antibodies with metal isotopes for mass cytometry (CyTOF)
Develop oligonucleotide-tagged RBR-2 antibodies for CITE-seq applications
Optimize RBR-2 antibodies for microfluidic single-cell Western blot systems
Spatial proteomics:
Validate RBR-2 antibodies for multiplexed immunofluorescence approaches like CODEX or CycIF
Adapt antibodies for in situ proximity ligation assays to detect RBR-2 interactions in individual cells
Develop branched DNA amplification systems for highly sensitive RBR-2 detection in tissue sections
Live-cell applications:
Generate cell-permeable nanobodies against RBR-2 for real-time monitoring
Develop reversible binding antibody fragments for dynamic protein tracking
Create split-fluorescent protein complementation systems with RBR-2-specific binders
RBR-2 antibodies offer valuable tools for investigating chromatin remodeling during DNA repair:
Sequential ChIP experiments to identify how RBR-2 associates with specific histone modifications during the DNA damage response.
Combined ChIP-seq and CUT&RUN approaches using RBR-2 antibodies to map genome-wide binding sites with high resolution.
Proximity-based approaches (BioID, APEX2) to identify chromatin remodelers that interact with RBR-2 at damage sites.
Isolation of specific chromatin fragments associated with RBR-2 using antibody-based chromatin purification followed by mass spectrometry to identify the protein composition of these regions.
Super-resolution microscopy with RBR-2 antibodies to visualize nanoscale chromatin organization changes during DNA repair.
Drawing from Arabidopsis RBR studies, researchers could explore whether RBR-2 associates with specific chromatin regions like heterochromatin (as 80% of RBR foci were found near heterochromatin) or with centromeric regions (as evidenced by detection of RBR foci together with CenH3) .